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A B S T R A C T
Background: High vegetable intake is associated with beneficial effects on bone. However, the mechanisms re-
main uncertain. Green leafy vegetables are a rich source of vitamin K1, which is known to have large effects on
osteoblasts and osteocalcin (OC) metabolism.
Objective: To examine the effects of consumption of two to three extra serves of green leafy vegetables daily on
bone metabolism.
Methods: Thirty individuals (mean age 61.8 ± 9.9 years, 67% male) completed three experimental phases in a
randomised controlled crossover design, each lasting four weeks, with a washout period of four weeks between
phases (clinical trial registration: ACTRN12615000194561). The three experimental phases were: (i) increased
dietary vitamin K1 by consuming green leafy vegetables (H-K; ~200 g/d containing 164.3 [99.5–384.7] μg/d of
vitamin K1); (ii) low vitamin K1 by consuming vitamin K1-poor vegetables (L-K; ~200 g/d containing 9.4
[7.7–11.6] μg/d of vitamin K1); and (iii) control (CON) where participants consumed an energy-matched non-
vegetable control. OC forms, total OC (tOC), carboxylated OC (cOC) and undercarboxylated OC (ucOC), were
measured in serum pre- and post-intervention for each experimental phase using a sandwich-electro-
chemiluminescence immunoassay.
Results: Pre-intervention tOC, ucOC and ucOC:tOC levels were similar between phases (P > .05). Following H-
K, but not L-K, tOC, ucOC and ucOC:tOC levels were significantly lower compared to pre-intervention levels
(P ≤ .001) and compared to CON (~14%, 31% and 19%, respectively, all P < .05), while cOC remained
unchanged.
Conclusions: In middle-aged healthy men and women, an easily achieved increase in dietary intake of vitamin
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T
K1-rich green leafy vegetables substantially reduces serum tOC and ucOC suggesting increased entry of OC into
bone matrix, where it may improve the material property of bone. In conjunction with previous epidemiological
and randomised controlled trial data, these findings suggest that interventions to increase vegetable intake over
extended periods should include bone end points including fracture risk.
1. Introduction
Previous work, including our own, has identified observational
evidence for a reduction in fracture risk associated with increased ve-
getable intake (Blekkenhorst et al., 2017a; Benetou et al., 2016).
However, the potential role of phytochemical constituents underlying
such benefit remains uncertain. Green leafy vegetables represent a rich
source of beneficial bioactive components including nitrate
(Blekkenhorst et al., 2017b) and vitamin K1 (Bolton-Smith et al., 2000),
both of which may have beneficial effects on bone (Klein-Nulend et al.,
2014; Mott et al., 2019). Vitamin K is obtained from two principle
sources including vitamin K1 (phylloquinone: PK) found predominantly
in green leafy vegetables including their oils and vitamin K2 (mena-
quinones: MK) primarily synthesized by bacteria and found in foods
such as meat, dairy and fermented products (Walther et al., 2013a).
Vitamin K plays an important role in the γ-glutamyl carboxylation
of numerous vitamin K dependant proteins (VKDP) (Hauschka et al.,
1989). VKDP are best known for their role in blood coagulation as well
as in the inhibition of vascular calcification (e.g. matrix Gla protein)
(Hauschka et al., 1989; Szulc, 2016). Clinically, vitamin K antagonists
are used as anticoagulants in individuals with cardiovascular disease,
with off-target effects on bone and blood vessel calcification reported
(Szulc, 2016; Binding et al., 2019). Vitamin K has also been implicated
in bone metabolism, with the non-collagenous VKDP, osteocalcin (OC)
synthesized exclusively in bone during its formation (Shea and Booth,
2016).
Osteocalcin is secreted by mature osteoblasts into the extracellular
matrix of bone and the general circulation (Gundberg et al., 2012).
Osteocalcin exists in the circulation in two major forms; carboxylated
OC (cOC) and undercarboxylated OC (ucOC). The cOC form is char-
acterised by the presence of 3 gamma-carboxyl groups on glutamic acid
residues and is important for bone integrity due to its high affinity for
hydroxyapatite (Gundberg et al., 1998). Alternatively, the ucOC form is
characterised by the presence of 0–2 gamma-carboxyglutamic acid re-
sidues (Hauschka et al., 1989). The ucOC fraction of total OC (tOC) in
serum has previously been shown to be inversely associated with vi-
tamin K status (serum PK) (Booth et al., 2004; Rehder et al., 2015). As
such, the ucOC fraction is now being used as a biological indicator of
vitamin K sufficiency (Booth, 2009). Current guidelines on vitamin K
reference values for Australia and New Zealand suggest adequate in-
takes of 70 and 60 μg/d for males and females respectively, for all ages
(National Health and Medical Research Council of Australia, 2006).
Slightly higher adequate intakes of 90 and 120 μg/d are recommended
for older males and females (≥51 years) in America (USDA. United
States Department of Health and Human Services, 2015). Whilst these
intakes may be adequate from the perspective of vitamin K-dependent
coagulation proteins (Binkley et al., 2002), the optimal vitamin K intake
for bone health remains unclear. Considering that higher vegetable
intake is universally promoted as part of a healthy diet, the aim of the
current study was to test whether extra consumption of green leafy
vegetables for four weeks would affect surrogate markers of bone me-
tabolism (OC forms) in healthy ambulant participants.
2. Materials and methods
The data for the current study were collected as part of the
Vegetable Intake and Blood Pressure (VIABP) Study
(ACTRN12615000194561) to determine if daily consumption of ni-
trate-rich vegetables (which are also high in vitamin K1) over four
weeks would result in lower blood pressure (Blekkenhorst et al., 2018).
In brief, the VIABP study was a randomised, open label controlled
crossover trial conducted at the Royal Perth Hospital Research Foun-
dation, Perth, Australia. The study included one screening visit (to
determine eligibility) and three experimental phases, each lasting for
four weeks that were preceded by a 4-week washout period. The three
experimental phases included: (i) high dietary nitrate intake via con-
sumption of green leafy vegetables; (ii) low dietary nitrate intake via
consumption of nitrate-poor vegetables; and (iii) no increase in vege-
tables (control; CON). As reported in the original investigation, despite
increases in plasma nitrate and nitrite after the green leafy vegetable
intervention, no effects on blood pressure were recorded (Blekkenhorst
et al., 2018). Nevertheless, green leafy vegetables are also a rich source
of vitamin K1 (Gebhardt et al., 2008). The high and low nitrate phases
in the VIABP study were used in the current investigation to represent
high vitamin K1 (H-K) and low vitamin K1 (L-K) phases, respectively.
Throughout the 24-week trial period, participants were required to
limit their intake of green leafy vegetables, except whilst undertaking
the H-K intervention (formerly termed high nitrate). Computer gener-
ated random numbers were used to assign participants to one of six
sequence orders for the three experimental phases (Blekkenhorst et al.,
2018). The VIABP study was approved by the University of Western
Australia Human Research Ethics Committee and was carried out in
accordance with the Declaration of Helsinki. All participants provided
written consent.
2.1. Participants
As detailed previously (Blekkenhorst et al., 2018), individuals with
pre-hypertension or untreated grade 1 hypertension were recruited
from the Perth general population. Sixty-five individuals were screened,
of which 32 were randomly assigned. Two participants withdrew after
randomisation due to medical reasons unrelated to the trial. Thirty
participants completed the study. All participants recruited were am-
bulant males and females aged between 40 and 74 years. These in-
dividuals had a resting mean ± SD systolic and diastolic blood pres-
sure of 134 ± 8 and 78 ± 8 mmHg, respectively. Exclusion criteria
have previously been described in detail (Blekkenhorst et al., 2018).
Briefly, participants were excluded if they: were a diabetic or a smoker,
had a body mass index ≥35 kg/m2 or < 18.5 kg/m2, or were taking
any of the following medications: antihypertensives, nitric oxide do-
nors, organic nitrates and nitrites, or related drugs.
2.2. Screening visit
Prior to commencing the study, participants attended a screening
visit. Anthropometric measurements obtained at the screening visit
included height, weight, waist circumference, and hip circumference.
After blood tests confirmed eligibility, participants were asked to return
to the research clinic to complete a medical examination by one of the
study physicians. Participants provided a list of current medications and
supplements, physical activity levels and a medical history. To calculate
physical activity levels, every 1 min of walking, moderate or vigorous
activity was multiplied by 3.5, 5.0 and 7.0 metabolic equivalents
(METs), respectively. Scores were subsequently summed to obtain total
METs/week (Australian Bureau of Statistics, 2013). During the
screening, participants completed a validated food frequency ques-
tionnaire (FFQ; Dietary Questionnaire for Epidemiological Studies
Version 2, DQES v2) (Ireland et al., 1994; Hodge et al., 2000; Giles and
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Ireland, 1996) to obtain baseline dietary intake. A Registered Nutri-
tionist supervised participants whilst completing the FFQ. Food models,
food charts, measuring cups and spoons were provided to ensure the
accuracy of reported food consumption.
2.3. Experimental phases: dietary intervention
Throughout each 4-week experimental phase, participants were
instructed to increase their vegetable intake by incorporating specific
vegetables blended into “juices” (the vegetables blended with water) or
a matching control beverage (energy matched using maltodextrin)
(Blekkenhorst et al., 2018). Participants were provided with a list of
vegetables that they could incorporate for the specific experimental
phases and were asked to maintain all meals as usual, with the excep-
tion of limiting vegetables that were high in nitrate typically also high
in vitamin K1. All intervention arms included the addition of one-
quarter of an orange flesh for taste. In the H-K and L-K experimental
phases, participants consumed 100 g/d of vegetables, blended with
approximately 200 mL of water before breakfast and dinner meals,
equivalent to increasing vegetable intake by ~2.7 servings/d
(~200–300 kJ/d) (National Health and Medical Research Council of
Australian Dietary Guidelines, 2013). Participants were provided with
blenders and were asked to blend ≥3 different vegetables of approxi-
mately equal weight. For the L-K intervention, participants were in-
structed that they could microwave, oven bake, boil, or steam any root
vegetables before consumption and were asked not to add any condi-
ments (e.g., cooking oil, salt). For CON, participants blended 8 g mal-
todextrin with the one-quarter of an orange in water (approximately
energy matched to the vegetables consumed in the H-K and L-K inter-
vention). To facilitate compliance and minimise potential loss-to-
follow-up, participants consumed a sample juice for all three inter-
ventions and completed a juice acceptability questionnaire to ensure
willingness to participate prior to being randomly assigned. Partici-
pants kept a diary of the type and weight of all vegetables consumed in
all prepared juices for the H-K and L-K phases. Compliance was assessed
using intervention diaries and has been reported previously
(Blekkenhorst et al., 2018). Finally, participants were asked to freeze a
small sample of each intervention juice in a sterile 5-mL tube in the
week before their post-intervention visit. Vitamin K1 concentrations
were determined for intervention juices for a random sample of 15
participants during both H-K and L-K experimental phases.
2.4. Estimation of dietary vitamin K
At the screening visit, dietary intake for the previous 12 months was
assessed from the FFQ. Based on this information, total vitamin K intake
was calculated from all listed food and beverage items (n = 101) in-
cluded on the FFQ, by multiplying the food item consumed (g/d) by the
mean vitamin K value (μg/g). Vitamin K1 (PK) values for FFQ food and
beverage items (n = 96) were obtained from the USDA National
Nutrient Database for Standard Reference (Release 28) (Gebhardt et al.,
2008). Vitamin K2 (MK-4 to MK-9) values (n = 43) for FFQ food and
beverage items were obtained from Schurgers and Vermeer (2000) and
MK-10 values (n = 6) for FFQ food items were obtained from Manoury
et al. (2013). Where foods and beverages containing vitamin K were not
available for FFQ items, a value of 0 μg/g was applied (PK n = 5; MK-4
to MK-9 n=58; and MK-10 n=95). For the vegetable juices consumed
in the experimental phases, vitamin K1 was calculated in a similar
manner using participant food diaries in-conjunction with the USDA
database (Gebhardt et al., 2008).
2.5. Biochemistry
Serum tOC was measured by sandwich-electrochemiluminescence
immunoassay using the Roche Cobas N-Mid OC assay (Roche
Diagnostics, Mannheim). The inter-assay coefficients of variation were
2.3% and 4.8% at levels of 18 and 90 ng/mL, respectively. Serum ucOC
was determined using the same reagent assay with pre-intervention of
the serum samples using 5 mg/mL of hydroxyapatite (Calbiochem),
based on the method of Gundberg et al. (1983). The inter-assay im-
precision for percentage binding of cOC was 8% and 12% at OC of 100
and 15 ng/mL, respectively.
2.6. Measurement of vitamin K1 in experimental beverages
Extraction procedures of vitamin K1 from juice was adapted from
the method by Gentili et al. (2014) and Schurgers and Vermeer (2000).
Briefly, 0.2 g of juice was weighed into 15 mL screw-capped poly-
ethylene centrifuge tubes then spiked with 5 ng of the K1-d7 internal
standard (Adrich cat # 705470). 1 mL of ethanol was added to denature
the proteins followed by, 2 mL of hexane and 1 mL of water for ex-
traction. Samples were vortexed and shaken for 3 min, followed by
further mixing for 15 min in a ultrasound bath, 20 min on a gyratory
mixer, and underwent 30 s of sonication. Subsequently, samples were
centrifuged at 1800 ×g for 6 min at 4 °C, with 1 mL of the upper hexane
layer purified on silica columns (Agilent Bond Elut Si, 500 mg) which
were preconditioned with ether (4 mL) and hexane (4 mL), the samples
was applied and washed with hexane (4 mL) and the vitamin K1 eluted
with hexane:ether (96.5:3.5 v/v). The purified solution was collected
then dried under N2 at 25 °C, and dissolved in 100 μl dichloromethane
for analysis by gas-chromatography mass spectrometry (GCMS) using a
DB-1HT column in electron impact mode and selected ion monitoring.
The K1-d7 internal standard was monitored at m/e 457.7 and K1 at m/e
450.7.
2.7. Statistical analysis
Statistical significance was accepted at a 2-sided type 1 error rate of
P < .05. All data were analysed by using IBM SPSS Statistics (IBM
Corp, Version 21.0. Armonk, NY) and STATA (Stata Statistical Software:
Release 15. College Station, TX: StataCorp LLC). Normality of dis-
tributions was tested with the use of the Shapiro-Wilk normality test.
Repeated measures ANOVA were used to examine if pre-treatment va-
lues for each OC form differed between interventions, as well as the
absolute change (pre- to post-treatment) in OC forms between inter-
ventions. Post-treatment differences for each OC form between inter-
ventions (H-K, L-K and CON) were tested using linear mixed effects
models with additional adjustments for pre-intervention levels.
Descriptive statistics of normally distributed continuous variables were
expressed as means± SD, non-normally distributed continuous vari-
ables were expressed as medians and IQR, and categorical variables as
numbers and proportions (percentage).
3. Results
Baseline clinical characteristics, demographics and dietary intake
for participants are presented in Table 1. Median [IQR] of total vitamin
K intake at the screening visit (assessed from the FFQ) was 136.7
[101.4–175.8] μg/d, with vitamin K1 from vegetables contributing 66.5
[41.1–93.5] μg/d. Based on participants' food diaries and the USDA
database (Gebhardt et al., 2008), the increase in vegetables in H-K, L-K
and CON was estimated to provide 324.2 [260.8–479.4] μg/d, 3.4
[3.3–3.7] μg/d and 0 μg/d, respectively, of vitamin K1. A list of vege-
tables consumed during H-K and L-K and their estimated vitamin K1
content are presented in Supplementary Table 1. The vitamin K1 levels
in H-K, L-K and CON juices, as analysed by GCMS, were 164.3
[99.5–384.7] μg/d, 9.4 [7.7–11.6] μg/d and 1.3 [0.8–2.9] μg/d, re-
spectively.
Pre-treatment OC forms were not significantly different prior to
each of the three experimental phases (Table 2, P > .05). Post-inter-
vention serum tOC, ucOC, cOC and ucOC:tOC levels for the three ex-
perimental phases are presented in Fig. 1. Post-treatment effects were
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recorded between interventions for tOC, ucOC and ucOC:tOC (all
P ≤ .001) but not cOC (P = .246). When compared to L-K and CON,
participants receiving H-K had lower levels of tOC (22.4 and 22.8 vs.
19.5 μg/L, respectively; P ≤ .001, Fig. 1a), ucOC (8.1 and 8.8 vs.
6.0 μg/L, respectively; P < .001, Fig. 1b) and ucOC:tOC (0.37 and 0.38
vs. 0.31, respectively; P < .001, Fig. 1d). Absolute change (pre- to
post-intervention) in tOC, ucOC and ucOC:OC was significantly greater
in H-K compared to L-K and CON (all P ≤ .01, Table 3).
4. Discussion
Our results demonstrate that short-term increases of ~200 g/d per
day of green leafy vegetable intake containing ~164 μg/d of vitamin K1
in H-K resulted in a 31% and 14% reduction in serum ucOC and tOC,
respectively, compared to CON. A previous dietary study of vitamin K1
supplementation through broccoli consumption at ~300 g/d (4 serves/
d), providing>500% of the adequate intake of vitamin K, according to
USDA guidelines (National Health and Medical Research Council of
Australia, 2006), for 6 days identified reduced ucOC, but not tOC
(Booth et al., 1999). In the current investigation tOC levels were ap-
proximately two-fold higher at baseline than those of the previous study
and fell after HK. These differences in results may be attributable to
recent developments in assay technology, given normalisation equa-
tions were used previously. Another important distinction to the
aforementioned work is that the current intervention used a wide
variety of green leafy vegetables, in an amount that is easily achievable
(~200 g/d); thereby increasing the ease of applying such dietary
changes.
Regarding mechanism of action, previous work that supplemented
1000 μg/d of pharmaceutical PK for two weeks reported substantial
reduction in tOC and the fraction of ucOC, without effects on other
markers of bone cell function including the osteoclast marker N-telo-
peptide of type I collagen or indeed another osteoblast marker bone-
specific alkaline phosphatase (Binkley et al., 2000). The authors pro-
posed that tOC may be the first biochemical marker of bone turnover
affected by PK supplementation, and other bone remodelling markers
could have been positively affected with a longer follow-up. Note-
worthy, in athletes with amenorrhea, PK supplementation resulted in
an unusual combination of increased bone formation markers with a
reduction bone resorption markers (Craciun et al., 1998). Contrarily, PK
supplementation (1 mg/d over 2 weeks) had no effect on markers of
bone cell activity apart from OC in postmenopausal forearm fracture
patients (Douglas et al., 1995). Nonetheless, it may be that the effect of
increased vitamin K on bone metabolism is to promote increased entry
of tOC into bone as identified by in vitro work (Atkins et al., 2009).
Specifically, observed effects in H-K may be a result of increased γ-
glutamyl carboxylation together with increased osteoblast-to-osteocyte
transition, while simultaneously decreasing the secretion of osteoclas-
togenic cytokines (Atkins et al., 2009). These results raise the possibility
of direct beneficial effects of improved OC binding to bone, which has
been associated with better material properties, particularly toughness
(Poundarik et al., 2012). Collectively, the aforementioned work may
help explain the positive influence that vitamin K has on bone forma-
tion and integrity.
Although the function of OC in bone is yet to be fully understood, in
epidemiological studies higher serum ucOC has been associated with
increased risk of hip fracture and reduced bone mineral density (Szulc
et al., 1996; Szulc et al., 1994). In older men, tOC has also been re-
ported to be more predictive of hip fracture risk than other markers of
bone cell activity; including serum collagen type I C-terminal cross-
linked telopeptide (CTX) and serum N-terminal propeptide of type I
collagen (P1NP) (Chubb et al., 2015). A separate investigation
(n= 1604, mean age 50 y) found that high serum fraction of ucOC was
associated with lower BMD at the hip (Booth et al., 2004). Noteworthy,
despite the aforementioned benefits for bone, some evidence from an-
imal models suggests that lower circulating levels of ucOC are asso-
ciated with increased risk of cardiometabolic disease (Tacey et al.,
2018). However, an RCT in older women (n = 1368, aged ~75 y)
demonstrated that 1 year of calcium supplements lowered ucOC by
22%, with no effect on glycated haemoglobin. These findings suggest
that animal models may not be applicable to humans (Lewis et al.,
2019). Given these conflicting finding, future work should explore how
changes in ucOC might influence other cardiometabolic outcomes.
Although most trials to date typically use large pharmaceutical
doses of vitamin K, an investigation reports older individuals (n= 888,
mean age 75 y) with the highest vitamin K intake (~250 μg/d) had a
65% lower relative risk for a hip fracture compared to those with the
lowest vitamin K intake (~60 μg/d) (Booth et al., 2000). An RCT per-
formed in post-menopausal women (n = 181, age ~ 55 y), compared
three experimental arms of: (i) placebo, (ii) calcium, magnesium, zinc,
and vitamin D, or (iii) the same formulation with additional vitamin K1
(1 mg/day) for 3 years (Braam et al., 2003). The vitamin K1 supple-
mented group showed less bone loss at the femoral neck (1.7% 95%Cl
0.35–3.44) compared to the placebo group, while no differences were
observed at the lumbar spine. There was an 8% reduction in tOC re-
corded at 3 months and 12 months, while ucOC was 72% lower at
12 months. Of note, no differences in other bone turnover markers (e.g.
bone alkaline phosphatase (BAP), deoxypyridinoline) were observed.
Despite the much larger vitamin K1 dose, these long-term results are
comparable to our findings, where post-intervention tOC was 14% and
ucOC 31% lower in H-K compared to CON.
Table 1
Demographic, clinical characteristics and dietary intake of study participants at
the screening visita.
All participants (n = 30)
Demographics
Gender (male/ female) 20/10
Age (range) 63.0 (55.5–70.5)
BMI 27.0 ± 3.9
Waist-to-hip ratiob 0.9 ± 0.1
Previous smoker,b n (%) 11 (37.9)
Physical activity, METs/weekb,c 1570 [720–2272]
Clinical blood pressure
Systolic blood pressure, mm Hg 133.6 ± 8.4
Diastolic blood pressure, mm Hg 77.7 ± 8.0
Dietary intake
Total energy, g/d 8204.4 ± 2885.5
Total vegetable, g/d 181.8 ± 75.8
Total fruit, g/d 256.1 [134.6–318.7]
Carbohydrate, g/d 202.8 ± 70.1
Protein, g/d 91.2 ± 34.7
Fat, g/d 80.6 ± 32.0
Alcohol, g/d 5.1 [0.8–17.0]
Vitamin K1, μg/d 116.2 [77.0–147.7]
Vitamin K2, μg/d 25.3 [20.5–33.8]
Total vitamin K, μg/d 136.7 [101.4–175.8]
a Values are means± SDs, medians [IQRs] unless otherwise indicated.
b n = 29.
c Metabolic equivalents; METs.
Table 2
Mean ± SD pre-treatment levels of total osteocalcin (tOC), undercarboxylated
osteocalcin (ucOC), carboxylated osteocalcin (cOC) and the ratio of ucOC to
tOC in the control (CON), low-vitamin K1 (L-K) and high vitamin K1 (H-K)
phases.
Pre-treatment P-value
CON L-K H-K
tOC (μg/L) 22.1 ± 6.3 22.5 ± 7.3 22.0 ± 6.4 0.937
ucOC (μg/L) 8.2 ± 4.0 8.0 ± 3.8 8.1 ± 3.5 0.971
cOC (μg/L) 13.9 ± 5.2 14.6 ± 6.2 13.8 ± 5.5 0.847
ucOC:tOC 0.37 ± 0.14 0.36 ± 0.15 0.38 ± 0.14 0.888
M. Sim, et al. Bone Reports 12 (2020) 100274
4
Similarly, in 381 postmenopausal women supplemented with PK
(1 mg/d), MK-4 (45 mg/d) or placebo for 12 months, despite PK and
MK-4 treatment reducing serum ucOC, other markers of bone metabo-
lism including BAP and N-terminal telopeptide of type 1 collagen were
unaffected. Furthermore, no benefits on lumbar spine or proximal
femur BMD or proximal femur geometric parameters were observed
(Binkley et al., 2009). Other work has also reported a lack of re-
lationship between vitamin K status (e.g. serum PK) (Booth et al.,
2004), dietary vitamin K intake (Booth et al., 2000) and bone mineral
density. Nevertheless when considering hard outcomes, two recent
meta-analyses examining the effect of vitamin K isoforms as a chemical
supplement (Mott et al., 2019) or as part of dietary intake (Hao et al.,
2017) report potential beneficial links for fracture risk reduction. Spe-
cifically, vitamin K supplements were associated with 28% lower clin-
ical fracture risk in post-menopausal and osteoporotic patients (Mott
et al., 2019). However, caution must be exercised when interpreting
these results as the vitamin K supplementation trials included a range of
pharmaceutical PK, MK-4 and/or MK-7 at dosages not attainable
though the diet alone. Finally, the authors of both the aforementioned
meta-analysis also suggested that more work is required to substantiate
study conclusions.
Our data confirms other work reporting that dietary vitamin K1
intakes of< 100 μg/d do not support the maximal carboxylation of OC
(Booth et al., 1999). Collectively, this suggests that existing adequate
intake reference levels of 70 and 60 μg/d for Australian men and
women may be too low (National Health and Medical Research Council
of Australia, 2006). There is currently no data on the average vitamin K
intake for Australian men and women. However, the average intake for
Americans from the 2011–2012 National Health and Nutrition Ex-
amination Survey was 138 and 122 μg/d for men and women, respec-
tively (National Center for Health Statistics, Centers for Disease Control
and Prevention, 2013). Specifically, despite an estimated vitamin K
intake of 137 μg/g at the screening visit here, the additional 164 μg/d
of vitamin K1 as part of H-K further reduced ucOC. Vegetables are es-
timated to contribute between 50 and 80% of consumed vitamin K1
(Shearer and Newman, 2014; Nimptsch et al., 2008; Schurgers et al.,
1999), with the largest concentration found in green leafy vegetables
with concentrations of up to 400–700 μg/100 g (Shearer and Newman,
2014). Of importance, vegetables also contain a range of other mac-
ronutrients and micronutrients that are associated with better muscu-
loskeletal health (Nicklett and Kadell, 2013). Considering only 7% of
Australian adults meet vegetable intake guidelines of 5–6 serves/d
(375–450 g/d) (National Health Survey, 2015), poor nutrition in
combination with insufficient physical activity may contribute towards
the high prevalence of musculoskeletal-related diseases, such as os-
teoporosis (Wade et al., 2014). Collectively, this paper raises an im-
portant public health issue regarding optimal vitamin K1 intake and
should be considered as part of strategies when promoting increased
vegetable intake. Noteworthy, as intestinal bacteria are also involved in
synthesizing MKs (Beulens et al., 2013), more research is needed to
Fig. 1. Effects of 4 weeks of control (CON), low vitamin K1 intake (L-K), and high vitamin K1 intake (H-K) vegetable juice on (a) total osteocalcin (tOC); (b)
undercarboxylated osteocalcin (ucOC); (c) carboxylated osteocalcin (cOC); and (d) the ratio of ucOC:tOC in serum. Post-intervention values are estimated
means± SE, adjusted for pre-treatment values.
Table 3
Mean ± SD absolute change in pre- to post-intervention serum total osteo-
calcin (tOC), undercarobxylated osteocalcin (ucOC), carboxylated osteocalcin
(cOC) and the ratio of ucOC to tOC in the control (CON), low-vitamin K1 (L-K)
and high-vitamin K1 (H-K) vegetable juice interventions.
Absolute change
CON L-K H-K
tOC (μg/L) 0.69 ± 1.84 −0.13 ± 2.23 −2.46 ± 3.44⁎
ucOC (μg/L) 0.62 ± 1.16 0.15 ± 1.41 −2.07 ± 1.82⁎
cOC (μg/L) 0.07 ± 1.71 −0.29 ± 2.05 −0.38 ± 2.75
ucOC:tOC 0.01 ± 0.04 0.01 ± 0.07 −0.07 ± 0.53⁎
⁎ Significantly different to CON and L-K, P ≤ .01.
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understand the role of the gut microbiome in contributing to overall
vitamin K status.
Strengths of this study relate to the randomised cross over study
design utilising two amounts of vegetable and the assessment of dietary
vitamin K using two separate methods. A power analysis also revealed
that this study was sufficiently powered to detect meaningful differ-
ences in all outcomes. Regarding limitations of this paper, the bioa-
vailability of vitamin K1 from foods can be reduced due to its poor bio-
accessibility from the food matrix. For example, about 10% of vitamin
K1 is typically absorbed from cooked vegetables, with vitamin K1 ab-
sorption slightly increased by the presence of dietary lipids (Schurgers
and Vermeer, 2000). Secondly, as vitamin K content in foods vary by
region (Schurgers and Vermeer, 2000), the amount of vitamin K1 in
green leafy vegetables consumed in Perth, Western Australia, is likely to
differ among other geographical locations. For example, the vitamin K1
content of the H-K juice estimated from the USDA database was ~50%
higher than that measured by directly by GCMS. Such findings are
consistent with previous work reporting large regional variations in the
vitamin K content of food (Walther et al., 2013b). As such, developing
region-specific vitamin K databases are an important consideration for
future epidemiological work assessing the relationship between vitamin
K intake and a range of health outcomes. Additional to vitamin K1,
green leafy vegetables are rich in nitrates that can positively influence
bone health (Klein-Nulend et al., 2014; Mott et al., 2019). Therefore,
any favourable effects of green leafy vegetable intake for bone health
might be related to a combination of nutrients found in such vegetable
varieties. Furthermore, the inclusion of an additional control group
presenting with clinical vitamin K deficiency may have yielded dif-
ferent results. Finally, the inclusion of supplementary markers of bone
metabolism (e.g. CTX, P1NP, BAP) and structure (e.g. BMD, broadband
ultrasound attenuation of the heel bone) would have been ideal to at-
tain more information regarding the relationship between green leafy
vegetables and bone health, especially in the context of a longer in-
tervention (e.g. 1–2 years).
5. Conclusion
Increasing green leafy vegetable intake over four weeks is a suffi-
cient method to reduce serum tOC. This may suggest improved osteo-
blast function by increasing OC entry into bone in otherwise healthy
middle-aged and older individuals. Whether such dietary interventions
over an extended period are able to improve bone integrity that also
translate to a reduction in the risk of fractures need to be explored.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bonr.2020.100274.
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